# Challenges and Insights in Patch-Clamp Studies: From Cell-Attached to Whole-Cell Configurations

**Authors:** Sheng-Nan Wu, Ya-Jean Wang, Rasa Liutkevičienė

PMC · DOI: 10.3390/cimb48020137 · Current Issues in Molecular Biology · 2026-01-27

## TL;DR

This paper discusses how patch-clamp configurations affect electrophysiological recordings and how drugs influence potassium channels in cells.

## Contribution

The paper provides insights into drug effects on specific potassium channels and the transition to AI in patch-clamp experiments.

## Key findings

- Switching from cell-attached to whole-cell patch-clamp increases current amplitude and abolishes action currents.
- Mitoxantrone suppresses Kir channels without altering single-channel conductance in RAW 264.7 cells.
- GAL-021 inhibits BKCa channels by shifting activation curves, acting as a gating modifier.

## Abstract

The patch-clamp technique is widely regarded as the gold standard in cellular electrophysiology and can be applied in several configurations. In the cell-attached (C-A) mode, it enables the recording of single-channel currents, whereas the whole-cell (W-C) mode allows for the measurement of macroscopic currents, representing the collective activity of many channels. When the recording configuration was switched from C-A to W-C on the same cell, the current amplitude increased dramatically, while action currents (ACs) were completely abolished, indicating a profound alteration in the cell’s electrophysiological response under the new setup. In excitable cells, the occurrence of ACs, representing propagated action potentials, can interfere with C-A single-channel recordings. To address this, a high-K+ solution is typically applied to the bath to suppress the ACs. The inwardly rectifying K+ (Kir), ATP-sensitive K+ (KATP) and large-conductance Ca2+-activated K+ (BKCa) channels are crucial members of the K+ channel family that facilitate the efflux of K+ ions, driven by the K+ electrochemical gradient. These channels are primarily distinguished by their rectification properties and gating kinetics. For instance, KATP channels exhibit a bursting kinetic pattern with inward rectifying property, while BKCa channels display strong outward rectification. Mitoxantrone, which belongs to a class of drugs called anthracenediones, can suppress the activity of Kir channels in differentiated RAW 264.7 cells, with no change in single-channel conductance. The respiratory stimulator GAL-021 acts as a BKCa channel inhibitor, and it suppresses channel activity and shifts the activation curve to the right, suggesting a voltage-dependent blockade that stabilizes the channel in a closed state. GAL-021 does not change the single-channel conductance, indicating it is a gating modifier rather than an open-pore blocker. The functional roles of ion channels are fundamentally important. Correspondingly, the field is transitioning to artificial intelligence for automated single-cell patch-clamp experiments, though brain slice recordings still require manual techniques.

## Linked entities

- **Proteins:** GEM (GTP binding protein overexpressed in skeletal muscle), Kcnma1 (potassium large conductance calcium-activated channel, subfamily M, alpha member 1)
- **Chemicals:** Mitoxantrone (PubChem CID 4212), GAL-021 (PubChem CID 57340959)

## Full-text entities

- **Genes:** Kcnj2 (potassium inwardly-rectifying channel, subfamily J, member 2) [NCBI Gene 16518] {aka IRK1, Kcnf1, Kir2.1}, Kcnma1 (potassium calcium-activated channel subfamily M alpha 1) [NCBI Gene 83731] {aka BKCA alpha, BKCa, KCNMA1b, KCNMA1c, KCa1.1, Kcnma}, Kcnma1 (potassium large conductance calcium-activated channel, subfamily M, alpha member 1) [NCBI Gene 16531] {aka 5730414M22Rik, BKCA alpha, BKCa, KCa1.1, MaxiK, Slo}, Gal (galanin and GMAP prepropeptide) [NCBI Gene 29141] {aka Galn}, Syt17 (synaptotagmin 17) [NCBI Gene 192189] {aka Bk}, Acsl1 (acyl-CoA synthetase long-chain family member 1) [NCBI Gene 25288] {aka ACS, Acas, COAA, Facl2}, Asah1 (N-acylsphingosine amidohydrolase 1) [NCBI Gene 84431] {aka Asah}
- **Diseases:** Multiple sclerosis (MESH:D009103), insulinoma (MESH:D007340), autoimmune demyelinating disorder (MESH:D003711), AC (MESH:D055577), cancer (MESH:D009369), injury to (MESH:D014947)
- **Chemicals:** ENA-001 (MESH:C000593146), anthracenedione (MESH:D000880), glucose (MESH:D005947), lipopolysaccharide (MESH:D008070), ATP (MESH:D000255), EPC (MESH:C075010), Na+ (MESH:D012964), K+ (MESH:D011188), 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione (-), Mitoxantrone (MESH:D008942), CaCl2 (MESH:D002122)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** GH3 — Rattus norvegicus (Rat), Rat pituitary gland neoplasm, Cancer cell line (CVCL_0273), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), INS-1 — Rattus norvegicus (Rat), Rat insulinoma, Cancer cell line (CVCL_0352)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939055/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939055/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939055/full.md

---
Source: https://tomesphere.com/paper/PMC12939055